Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1

Biomedicine and Pharmacotherapy

Volumn 67, Issue 6, 2013, Pages 521-526

  Fan, Conghai ^a   Liu, Sheng ^b   Zhao, Yupeng ^b   Han, Youqun ^c   Yang, Longqiu ^d   Tao, Guorong ^e   Li, Qing ^f   Zhang, Lei ^g  

^a XUZHOU CHILDREN S HOSPITAL   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d FIRST HOSPITAL OF SHIJIAZHUANG   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^g SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Cycle progression; FOXO1; Gastric cancer; MicroRNA370; Proliferation

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA; MICRORNA 370; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOMA; UPREGULATION;

CYCLE PROGRESSION; FOXO1; GASTRIC CANCER; MICRORNA370; PROLIFERATION;

CELL CYCLE PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICRORNAS; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84880965298     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.04.014     Document Type: Article

References (21)

1. Katoh M., Katoh M. Human FOX gene family (Review). Int J Oncol 2004, 25:1495-1500.
2. Paik J.H., Kollipara R., Chu G., Ji H., Xiao Y., Ding Z., et al. FOXOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007, 128:309-323.
3. Katoh M., Igarashi M., Fukuda H., Nakagama H., Katoh M. Cancer genetics and genomics of human FOX family genes. Cancer Lett 2013, 328:198-206.
4. Gao J., Yang X., Yin P., Hu W., Liao H., Miao Z., et al. The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer. Int J Oncol 2012, 40:1203-1209.
5. Hoekstra A.V., Ward E.C., Hardt J.L., Lurain J.R., Singh D.K., Buttin B.M., et al. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. Gynecol Oncol 2008, 108:609-618.
6. Kim T.H., Jo S.W., Lee Y.S., Kim Y.J., Lee S.C., Kim W.J., et al. Forkhead box O-class 1 and forkhead box G1 as prognostic markers for bladder cancer. J Korean Med Sci 2009, 24:468-473.
7. Xie L., Ushmorov A., Leithauser F., Guan H., Steidl C., Farbinger J., et al. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood 2012, 119:3503-3511.
8. Kim S.Y., Yoon J., Ko Y.S., Chang M.S., Park J.W., Lee H.E., et al. Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules. BMC cancer 2011, 11:264.
9. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
10. Liu F.J., Wen T., Liu L. MicroRNAs as a novel cellular senescence regulator. Ageing Res Rev 2012, 11:41-50.
11. Henry J.C., Azevedo-Pouly A.C., Schmittgen T.D. MicroRNA replacement therapy for cancer. Pharmaceut Res 2011, 28:3030-3042.
12. You J.S., Jones P.A. Cancer genetics and epigenetics: two sides of the same coin?. Cancer cell 2012, 22:9-20.
13. Kim K.M., Park S.J., Jung S.H., Kim E.J., Jogeswar G., Ajita J., et al. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J Bone Miner Res 2012, 27:1669-1679.
14. Guttilla I.K., White B.A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009, 284:23204-23216.
15. Lo S.S., Hung P.S., Chen J.H., Tu H.F., Fang W.L., Chen C.Y., et al. Overexpression of miR-370 and downregulation of its novel target TGF beta-RII contribute to the progression of gastric carcinoma. Oncogene 2012, 31:226-237.
16. Barr F.G. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 2001, 20:5736-5746.
17. Lin H., Dai T., Xiong H., Zhao X., Chen X., Yu C., et al. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PloS one 2010, 5:e15797.
18. Wu L., Li H., Jia C.Y., Cheng W., Yu M., Peng M., et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett 2012, 586:1038-1043.
19. Zhang X., Zeng J., Zhou M., Li B., Zhang Y., Huang T., et al. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia. Mol Cancer 2012, 11:56.
20. Cao X., Liu D., Yan X., Zhang Y., Yuan L., Zhang T., et al. Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor. FEBS Lett 2013, 587(6):639-644.
21. Wu Z., Sun H., Zeng W., He J., Mao X. Upregulation of mircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PloS one 2012, 7:e45825.